Physician profile
John M Luber
NPI 1801821756
$622,733.34
in general payments reported to CMS, 2019-2025
9 companies · $89K in 2025
The $89K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171K · 2020: $40K · 2021: $72K · 2022: $65K · 2023: $84K · 2024: $102K · 2025: $89K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $205K · Travel and Lodging: $37K · Consulting Fee: $29K · Food and Beverage: $4,863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $204,657.50 |
| Travel and Lodging | $36,523.17 |
| Consulting Fee | $29,434.92 |
| Food and Beverage | $4,863.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $470,615.69 | 2019-2025 | Kcentra |
| Janssen Pharmaceuticals, INC | $99,466.10 | 2019-2024 | Xarelto |
| Btg International INC. | $32,300.37 | 2024-2025 | |
| Medtronic, INC. | $12,554.31 | 2021-2023 | Avalus |
| Medtronic Vascular, INC. | $6,253.51 | 2019-2020 | |
| Janssen Research & Development, LLC | $1,198.10 | 2023 | |
| Edwards Lifesciences Corporation | $290.46 | 2022 | |
| Ethicon US, LLC | $54.80 | 2019-2025 | Stratafix |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Luber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.